DatasetName,FKBP5_S(392) FKBP5_T(451),FKBP5_S(13) FKBP5_S(256) FKBP5_S(445) FKBP5_S(448) FKBP5_S(5) FKBP5_T(15)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.4751268884247863
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.4477085048303202
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.4588633163786813
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.4497281864127933
HS2024_6_B_T3,,0.48743168076176596
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.4921755811515567
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.4617752635404995
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.5065738618188474
DB2022_Intensity L2,,
TM2022_mock.4h.C,,0.488306690284439
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,0.439108897904559
FSO2013_Ratio M/L normalized Rep1___1,,0.49216778638456843
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.47377438272770656
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.488479231645575
WZ2023_Pu_010_30min,,0.48884771756540424
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.4837683405394008
RB2022_8_RecoveryEndurance,,0.49294389207270495
KBE2022_Log2_Ex_14_U,,0.5017654221404705
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.48423929001522054
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,0.4788201888711403
PG2020_Intensity 8h_C,,0.45618608596302074
AH2018_SILAC_MR_2_N,,0.4769423525057636
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,0.4882421707755076
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.463837382124221
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5278569548327074
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.4789673400306714
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.46943041652363116
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,0.48434559008626016
RB2022_5_PostStrength,,0.49739078839446726
GF2025_P6_Sph,,0.46545954593986766
RB2022_2_PreSprint,,0.46852513013110947
ZX2022_CB treated Replicate 3,,0.4564912618925075
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.5221540513307049
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,0.5047748256280405
WZ2023_Pu_005_10min,,0.5089330536157856
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.48550482646412957
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,0.5017697261518176
AH2018_SILAC_MR_2_X,,0.4909843083033729
HS2024_4_PD_T2,,0.4587747318634834
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,0.47179430484899293
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5000693073964705
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.477549995774781
CR2017_Ratio Replicate 1.3,,0.4922583928511135
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.4858655484295149
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.4741858257255796
HS2024_7_PD_T2,,0.457490654677925
FSO2013_Ratio H/L normalized Rep1___1,,0.49852816883011214
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.5085121652703306
HS2024_3_B_N1,,0.45760753862652387
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.4880179519270717
CK2022_11 40-1,,0.48558523903998535
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.47948675956978365
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,,0.5090944894337676
WZ2023_Pu_005_20min,,0.48335738638463605
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.49708585370547126
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.5090174825946209
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.44313730173901716
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.4739666033698378
HS2024_9_B_T2,,0.4507248680178784
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.4987920528885896
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,0.49516163797813917
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.49074230788630896
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.4309169750513915
CK2022_1 200-1,,0.46848551971141533
PG2020_Intensity Mock_10h_D,,0.4593653307988512
SR2019_MCF10A_Biol_repl_2,,0.5008487505121978
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.4819258505581366
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.49385169702132187
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,0.48677552238817
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.4833361873792108
PG2020_Intensity 2h_C,,0.43296996739946475
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.45368556288378564
KBE2022_Log2_Ex_8_T,,0.4925775923635792
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,0.4659931501291344
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,0.5065085651139137
AH2018_LFQ_M_2_C,,0.43231212379361
CK2022_3 40-1,,0.4405739654630462
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.4611012498457536
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.4815857678131274
EJN2021_5_Rest_Basal,,0.47545598739451567
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.45283344889621285
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.47798895109102757
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,0.5018922439786128
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.47325656745743433
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.42977973439724537
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.46970025024851475
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.4782411746221336
HS2024_8_I_T3,,0.45876941756047707
CF2017_EOC 3,,0.4572163947610453
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.4510788699327895
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.502658356957722
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.4426375261673956
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.4525785409727853
CK2022_8 16-1,,0.44435694096418815
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,0.4794058649226149
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.47651137965641244
FSO2013_Ratio H/M normalized Rep2,,0.4856124770048517
RAM2015_Log2 A,,0.4742206975355327
HS2024_8_PD_T1,,0.47684049613117674
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.48645926837497333
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,0.4564597516087834
PG2020_Intensity 8h_A,,0.46456017620616086
HS2024_7_I_T1,,0.4749496449045381
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.47491675807725775
AH2018_SILAC_M_3_X,,0.4860830511569912
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.4827428662777611
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.48896840595947033
HS2024_6_B_N1,,0.4675490879365949
KBE2022_Log2_Ex_27_T,,0.5143809923871064
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,0.480023573004535
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.48177273336153675
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5204641007109325
AH2018_SILAC_IT_3_X,,0.46519197376483584
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.4688461804870223
FSO2013_Ratio M/L normalized Rep2,,0.4916475445708513
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,0.4652787066034065
CK2022_14 40-1,,0.4453322839397669
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.4625355099603119
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.44717054142819634
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.48312312343782565
EJN2021_4_Rest_Ins,,0.4731683371750841
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.44553357566084006
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.47592318495342184
EJN2021_1_Rest_Ins,,0.4760301069309561
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.4576379765172575
JW2021_After_3,,
GF2025_P8_Sph,,0.518554099282191
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.47364969592423223
CK2022_11 200-1,,0.5128221742501161
CK2022_12 200-1,,0.5062833335099725
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,0.47126104057414064
AH2018_TMTMS2_2_N,,0.4870895960427955
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5107042983506416
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.46773552593467055
AH2018_TMTMS3_Pool,,0.47208492474056757
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.4394522424962181
CK2022_14 200-1,,0.47284358620078254
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.44931130291073296
TM2022_mock.4h.A,,0.48438513612484746
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.4767864442172562
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.46364399757514246
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.47509126572959665
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.4433741122804202
GF2025_P1_Adh,,0.4736391500677903
GF2025_P1_Sph,,0.4533066844484451
EJN2021_5_Ex_Basal,,0.47449784819101404
HS2024_7_I_T3,,0.4495091078474523
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.5066262799807651
CF2017_EOC 1,,0.4423733470636511
CK2022_3 200-1,,0.4681957805428008
AH2018_LFQ_IT_3_C,,0.45442637406464353
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.47441065914220987
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.5221888225017585
HS2024_5_B_T1,,0.4847658330602485
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.4920699935758012
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.4400237549590373
RB2022_1_PostSprint,,0.462629871792033
CK2022_4 200-1,,0.46867019244548397
JW2021_Before_2,,
TM2022_S2.12h.A,,0.4892906109963266
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.43994933286586485
AR2021_ALG 1 μM,,0.47900451805567384
HS2024_4_B_T1,,0.4554122664987925
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.4798479269559455
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.4411522780883614
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.460585857035192
CK2022_9 16-1,,0.507727967607725
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.4707264880305648
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.45680958175679764
CK2022_16 16-1,,0.4414013888750598
FS2019_db/db3,,
CK2022_15 40-1,,0.4431291314486188
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.48169653981027905
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5126236402073943
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.479421316712719
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.44300224434182917
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.49740604407158634
AH2018_LFQ_M_1_N,,0.45130151838524596
KBE2022_Log2_Ex_27_U,,0.5078178373032188
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.4770826367529872
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.5057617138622967
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.4823560338158727
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.4675944660826996
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,0.4542525962106902
CK2022_12 16-1,,0.49721142903822385
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.5045509429657279
SR2019_SKBR3_Biol_repl_3,,0.47077295800703095
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.4985414734863735
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.4502416607665975
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.4895031065093673
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.4851540875674383
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.4602339635226958
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,0.5256728778278291
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.41937742760670194
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.4974875969216108
GF2025_P3_Adh,,0.45326088545228554
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.47211472350350353
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.4368567855166849
KBE2022_Log2_Ex_19_U,,0.49732356292693
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,0.4897615285389249
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.49060443761923844
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,0.4714187751941561
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,0.4829775477781124
AH2018_LFQ_1_X,,0.48006599191763016
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.4654488128870076
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.4652086465506586
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.4529649230063133
EP2017_Untreated R#2 log2 ratio,,0.4498074352634534
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.4946481594818697
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.4847398639829576
AR2021_KD 72h,,0.47244426202057666
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.5148697994176958
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.46851096297413664
KBE2022_Log2_Ex_9_U,,0.492347464569942
AH2018_SILAC_M_3_N,,0.4784202970235707
KBE2022_Log2_Ex_13_T,,0.50376438358226
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.45333501721257613
CF2017_OSE 29,,0.47799578722309627
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,0.4189784588031335
PG2020_Intensity 10h_A,,0.4676703639001469
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.45334209937613634
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.4683243614625594
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.48987742358875147
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.4522306792937571
RB2022_7_RecoveryEndurance,,0.5123778991298372
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.4749447855143885
TM2022_S2.12h.B,,0.4890229683584799
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,0.4857173450871582
PG2020_Intensity 4h_A,,0.45948403440919794
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,0.48587232318556683
KBE2022_Log2_Ex_24_U,,0.5023732252336527
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,
RB2022_1_PreSprint,,0.48048140681527535
HS2024_4_I_N1,,0.4308744000921787
CK2022_7 200-1,,0.46970419457760676
CK2022_5 200-1,,0.4687023458020862
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5100339845798998
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,0.4747015015565765
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.49673863535944535
AH2018_SILAC_3_C,,0.45332850263193
EJN2021_5_Rest_Ins,,0.47442407716026197
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.470927967741408
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.4648841709568141
CK2022_4 16-1,,0.4376222067963395
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.4791003691770623
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,0.4720996262837005
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.4240704126335088
FSO2013_Ratio H/L normalized Rep3,,0.48420508229041803
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.45159740986159874
KBE2022_Log2_Ex_9_T,,0.5027758967860978
AH2018_SILAC_IT_2_N,,0.4902674629555026
AH2018_SILAC_IT_1_X,,0.4492588938061175
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.45723116912560274
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.46024193499474636
WZ2023_Pe_025_20min,,0.4819642078589248
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,0.509798888304837
AH2018_TMTMS2_3_N,,0.48818101230424854
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.4538054234212363
WZ2023_Su_005_30min,,0.48359375817538414
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.4744073890546436
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.4576373134884131
WZ2023_Su_025_10min,,0.5001449887671604
AH2018_LFQ_IT_4_X,,0.4858469072153972
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,0.4810067878579314
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.47487704354223087
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,0.44679869233190894
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,0.46547310857651997
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.4602140095976039
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.45830488177387335
LY2019_P7+,,0.5114008812027788
EP2017_Untreated R#1 normalized log2 ratio,,0.445871446598841
RN2012_L10,,
PG2020_Intensity 4h_C,,0.45977181100107495
EP2017_Mitotic R#3 normalized log2 ratio,,0.4884446620878024
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.5096431261070178
RB2022_8_PostStrength,,0.4580042102949895
AH2018_SILAC_IT_2_X,,0.48377099787910954
HS2024_4_B_T3,,0.46220856278305167
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.4879730099840407
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.49542747138059723
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.4672975924478379
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.4997746415194266
GF2025_P9_Sph,,0.5226265516180234
CK2022_6 200-1,,0.46932072401424696
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.4427470577686771
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.46644142790187343
HS2024_4_I_T2,,0.44408689698521203
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,0.44908163347778984
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.4706441728382147
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,0.478440943836155
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.4577151887327254
EP2017_Untreated R#3 normalized log2 ratio,,0.5006374443005384
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.4709575010131546
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.48526568347823523
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,0.4906487507372293
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.46434929010288
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.45439732826263707
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.430413619840105
KBE2022_Log2_Ex_29_T,,0.5126729781771083
HS2024_7_I_T2,,0.45152474302408896
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.4943523664865017
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.47912072789863913
FR2021_Intensity.M,,
RB2022_2_PostSprint,,0.4630881566321885
AH2018_SILAC_MR_3_N,,0.4771662306225952
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.465113632816859
PG2020_Intensity CT_C,,0.4492246234213986
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.4948929662950389
EP2017_Untreated R#3 log2 ratio,,0.5009986818043731
RB2022_2_PostStrength,,0.4756865647417123
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.44583661193181273
HS2024_8_PD_T2,,0.49230264685338626
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5235012070444415
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.48108129286649165
CR2017_Ratio Replicate 2.3,,0.46878821138269267
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.4365935007473398
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.4695677547870029
HS2024_3_PD_T3,,0.4671702425834005
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.47441128724963066
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.46323133681305223
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.4971639194555153
CK2022_2 16-1,,0.4265071877395381
RAM2015_Log2 B,,0.47840420617427676
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.4777639038336268
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,0.45808813586061525
HS2024_6_B_T1,,0.49408880058618926
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,0.46357375083179697
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.4356800288583487
PG2020_Intensity Mock_10h_B,,0.4573654593420096
WZ2023_Su_025_30min,,0.46843278053286636
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,0.5225592601124528
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.48884424876317256
RB2022_7_PreEndurance,,0.4375851079540605
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5221555569293214
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.46925667736735516
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.4917224775541928
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.45941189037684227
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.463369082978258
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.4784033938348327
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.4629757477544009
GF2025_P9_Adh,,0.48924695501516285
RB2022_3_PostStrength,,0.4692917316416911
TM2022_S2.8h.A,,0.4866468172051697
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.46345005159327574
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.47247229979396604
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.45345636295017916
AH2018_LFQ_2_X,,0.49044459557715686
PG2020_Intensity 2h_B,,0.4456424207956166
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,,0.4566201911160894
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.4589039948185638
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.45057606789216836
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.48700622313662717
ZQ2022_N1,,
LY2019_P6-,,0.524643576274915
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,0.46605434351854164
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,0.5006368613184722
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.5102044104826423
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.4572455344984518
RB2022_1_RecoverySprint,,0.44697268059418716
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.45260421532043144
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.45163807098275505
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.48325057812648486
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.4125144077401071
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.49476657299130355
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.44564735806891037
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.4707997087976057
RB2022_8_PreEndurance,,0.4491094107391049
HS2024_3_B_N2,,0.49196132634431367
EJN2021_4_Ex_Ins,,0.4772273239426592
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.4785594123830023
EP2017_Pervanadate R#3 log2 ratio,,0.46992433501980896
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.4772557832881317
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,0.44929086831457954
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.512486263620695
LY2019_P3-,,0.44928257899401136
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.47906349365598827
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.484517178007615
HS2024_8_PD_T3,,0.47453665293059605
EJN2021_3_Ex_Basal,,0.47617469276110097
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.45411816934076527
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.478378435059377
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.4585866089621522
RB2022_1_RecoveryStrength,,0.5100816324527497
SR2019_HCC1954_Biol_repl_4,,0.4657844671990346
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.4722464912144379
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.46386934707961763
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.4847265546424267
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.46148424812933914
LY2019_P8+,,0.42833696667728866
RB2022_2_RecoveryEndurance,,0.4842109524156904
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.47717064594100983
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.4822844540196452
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.5031029182663681
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.49660904655058263
LY2019_P2-,,0.4909765334757834
AH2018_LFQ_IT_1_X,,0.4885849255100596
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.436510609180963
WZ2023_Pe_005_20min,,0.46784083169572765
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.47919948377415217
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.44048848301517013
SR2019_MCF10A_Biol_repl_4,,0.493834092898972
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.4813084496792454
HS2024_5_B_T2,,0.4734094445495131
HS2024_6_I_T1,,0.44351681126798476
HS2024_5_B_T3,,0.49743561193954317
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.5019143443221119
AH2018_TMTMS3_3_N,,0.47795165958621366
SR2019_HCC1419_Biol_repl_2,,0.47690733632957844
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.4754835294496858
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.49092405551494617
KBE2022_Log2_Ex_36_T,,0.5022649808910052
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.4578119045930204
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.49335649756695915
CK2022_9 200-1,,0.512303489881917
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5114878841214946
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.45086285781287166
RBK2021_1332T Late,,
LY2019_P1-,,0.5366747922426218
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.4728064938486734
HS2024_3_I_T3,,0.49633940868340004
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.47665749894972326
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.5043113891336405
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.44612427554270795
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.49089809751448454
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,0.4791697400698121
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,0.4866024055660902
CR2017_Ratio Replicate 1,,0.5075732304978579
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.4837224327264786
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.4506576888862465
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.46218711621352054
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,0.4684975995599383
AR2021_KD 48h,,0.47188905016807664
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.46979310170813937
HS2024_5_I_T1,,0.505275021540427
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.48179311154397664
KBE2022_Log2_Ex_29_U,,0.5030272828089969
HS2024_7_B_T1,,0.5112438018764431
AH2018_LFQ_M_2_X,,0.4941779674971751
AH2018_LFQ_IT_4_N,,0.477988101327389
CK2022_15 200-1,,0.46832829853871294
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.5087017690133011
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.45205889404581273
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.4676329146310401
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.4721446369902204
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.4747647706054847
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.4598526763842268
HS2024_8_B_T3,,0.4759639255562
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,0.5116978457393012
WZ2023_Pe_010_20min,,0.48638344969706554
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,0.46934559107788915
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,,0.48463733370020295
AH2018_SILAC_M_3_C,,0.4545107701011979
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.45563838966389475
AH2018_SILAC_M_2_X,,0.4785746433254428
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.5172601552924901
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.47072063722941476
PG2020_Intensity 6h_C,,0.4550983526196443
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.4708512540015679
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.4749488642601369
CK2022_15 16-1,,0.43834921394140647
CK2022_3 16-1,,0.43146737655038886
LY2019_P4-,,0.4104701489911451
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,0.4811825481987943
GF2025_P8_Adh,,0.5163893226310287
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5012545790183213
CK2022_10 16-1,,0.504484750892143
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4744893111955761
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.5021754189485703
EJN2021_2_Ex_Basal,,0.47431410638835575
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.4984567559845711
AR2021_L41 10 μM,,0.49608799109182566
CF2017_EOC 2,,0.473536768498869
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.4765434607239083
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.5053624866669807
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.4674024360734987
CK2022_6 16-1,,0.4427938141457077
ZX2022_CB treated Replicate 1,,0.4533607597065608
BS2014_Log2(Ratio H/L normalized Rep_3),,0.47687458728822696
TM2022_mock.12h.C,,0.49035906139479807
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.47278431680834215
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.49350360779318
AR2021_L41 1 μM,,0.505872594038561
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.4804782767929498
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.4475768956066144
KS2014_Intensity C4,,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.4989138880821438
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.4917423714447487
HS2024_7_B_T2,,0.4668424456038507
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.4944728628890995
AH2018_SILAC_IT_3_C,,0.47276449952013944
WZ2023_Pu_025_10min,,0.5041376606717297
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.4742544939217417
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.45647255516294766
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.4739367042788338
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.4735307844282744
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.47753662546899145
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.45417814760116554
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.44190761120742855
AH2018_SILAC_IT_2_C,,0.4896600726393337
CK2022_5 40-1,,0.4478002500571394
AH2018_LFQ_3_X,,0.4880484879099538
UK2020_UA_3,,
LY2019_P7-,,0.47886566456255575
GF2025_P5_Adh,,0.4311767062300362
RB2022_1_PostStrength,,0.46047766750394675
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.4849700274702846
SR2019_HCC1954_Biol_repl_3,,0.4644662958284255
CR2017_Ratio Replicate 2.2,,0.4817247116635615
VOI2024_0.1uM 2 h_1 mono,,0.45432871018894483
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.4532152058184124
CK2022_11 16-1,,0.5051320446072306
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.4631290966337877
PG2020_Intensity CT_B,,0.46067315246984925
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.4768446983488388
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.4916211717696977
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.47669005888209265
RB2022_2_PreEndurance,,0.4933439015554411
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.5048860823901888
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.44880184155662856
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.5139203523228505
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,0.4783454275647258
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,0.4535928295201188
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.4958474553658559
AH2018_TMTMS2_1_X,,0.4939107887789988
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,0.48119899134901184
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.4681880736639683
HS2024_6_I_N2,,0.4603499291502893
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,0.49070823385412843
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.470629935338671
HS2024_4_I_T3,,0.46800283110547053
AH2018_SILAC_1_X,,0.48858504022700827
PG2020_Intensity 10h_B,,0.46388085276938434
AH2018_TMTMS3_1_X,,0.44221213469463355
CF2017_FTE 14,,0.4708483303027487
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.44726822000929817
SR2019_HCC1419_Biol_repl_3,,0.4740047775828356
KBE2022_Log2_Ex_14_T,,0.5132552506681648
EP2017_Untreated R#2 normalized log2 ratio,,0.44968830391091963
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.4712158132046372
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.46492499093434825
AS2011_Ratio H/L Normalized RNAi_2_1,,
